Boston Scientific rises on Q3 results beat

Boston Scientific

22/10/2025 11:44

** Shares of medical device maker Boston Scientific BSX.N rise 4.1% to $104 premarket

** Co reports Q3 adjusted profit of 75 cents per share, beating estimates of $71 cents per share, according to data compiled by LSEG

** Posts Q3 revenue of $5.06 billion vs an estimate of $4.96 billion

** BSX estimates YoY net sales growth for Q4  to be in a range of 11% to 13% on organic basis

** As of last close, BSX stock up 11.8% YTD

(Reporting by Padmanabhan Ananthan)

((Padmanabhan.Ananthan@thomsonreuters.com))